Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

Not My Time to Say Goodbye

March 23rd 2015, 5:04pm

Article

Saying goodbye to a friend in the middle of a shared cancer diagnosis can challenge the soul.

A Beautiful Life of Cancer Denial

March 5th 2015, 2:22am

Article

Living in denial is sometimes not such a bad idea, especially when it comes to cancer.

We Are The 30%

February 27th 2015, 1:32am

Article

Metastatic breast cancer will strike 30% of all breast cancer survivors yet only 2% of funds go to research this deadly cancer.

Clinical Implications of Ibrance's Approval for Metastatic Breast Cancer

February 12th 2015, 10:43pm

Article

Richard Finn, of the Jonsson Comprehensive Cancer Center at UCLA and lead investigator of the PALOMA-1 study, explains the clinical implications of Ibrance's approval for hormone-positive, HER2-negative metastatic breast cancer.

Ibrance Approved for Metastatic Breast Cancer

February 4th 2015, 7:17am

Article

The anticipated approval of Ibrance (palbociclib) came two months ahead of expectations, as the FDA granted an accelerated approval to the drug as a frontline treatment for women with ER-positive, HER2-negative metastatic breast cancer.

The BEST New Year's Eve

January 2nd 2015, 1:08am

Article

When was your last truly remarkable New Year's Eve?

Overcoming the Mental Battle of Metastatic Cancer

December 24th 2014, 2:51am

Article

The mental challenges of having stage 4 breast cancer are just as overwhelming as the physical ones.

Firstline Kadcyla Results Disappointing in HER2-Positive Metastatic Breast Cancer Trial

December 19th 2014, 10:50pm

Article

Two HER2-targeting regimens anchored by Kadcyla (T-DM1) failed to outperform the standard strategy of Herceptin plus chemotherapy in women newly diagnosed with advanced HER2-positive breast cancer.

Upfront Faslodex Improves Survival Over Anastrozole in Estrogen-Positive Metastatic Breast Cancer

December 17th 2014, 1:29am

Article

Faslodex (fulvestrant) improved overall survival by nearly six months compared with anastrozole as initial hormone therapy for postmenopausal women with estrogen receptor-positive advanced breast cancer, according to findings from the phase 2 FIRST trial.

Advocates Call for More Attention to Metastatic Breast Cancer

December 12th 2014, 10:52am

Article

Karen Durham never expected to be speaking on behalf of the Metastatic Breast Cancer Alliance